Daryl Pritchard, Ph.D., is the Senior Vice President for Science Policy at the Personalized Medicine Coalition (PMC), where he leads the Coalition’s efforts to develop and promote optimal science-related policies and to increase awareness and understanding of personalized medicine among health care providers, patients, policymakers, and other stakeholders. This includes working to identify and address barriers to the clinical adoption of personalized medicine, including the development and promotion of appropriate clinical, infrastructure, regulatory, and payment policies.
Before coming to PMC, Dr. Pritchard served as the Director of Policy Research at the National Pharmaceutical Council (NPC), where he directed NPC’s policy research efforts in the areas of personalized medicine, the heterogeneity of treatment effects and the value of specialty biopharmaceuticals, and helped to advance NPC’s outreach, alliance development, and government relations.
Prior to joining NPC, Dr. Pritchard served as the Director of Research Programs Advocacy and Personalized Medicine at the Biotechnology Innovation Organization (BIO), where he led the organization’s policy and research efforts regarding diagnostics and personalized therapies as well as the coordination of BIO’s activities involving federal biomedical research programs. He also spent three years as the Director of Government Affairs for the American Association for Dental Research and as the primary research policy coordinator for the American Dental Education Association.
Dr. Pritchard received his Ph.D. and master’s degree in genetics from George Washington University, and completed a post-doctoral research fellowship at the Children’s National Medical Center. He was awarded the first American Society of Human Genetics/National Human Genome Research Institute Fellowship in Genetics and Public Policy, where he worked as a legislative assistant in the House of Representatives.
